KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $4.1 billion.

  • Novartis Ag's Other Non-Current Liabilities rose 142.33% to $4.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.1 billion, marking a year-over-year increase of 142.33%. This contributed to the annual value of $4.1 billion for FY2025, which is 142.33% up from last year.
  • As of Q4 2025, Novartis Ag's Other Non-Current Liabilities stood at $4.1 billion, which was up 142.33% from $4.1 billion recorded in Q3 2025.
  • Novartis Ag's Other Non-Current Liabilities' 5-year high stood at $6.3 billion during Q3 2021, with a 5-year trough of $4.1 billion in Q4 2024.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $4.7 billion (2023), whereas its average is $4.9 billion.
  • Per our database at Business Quant, Novartis Ag's Other Non-Current Liabilities plummeted by 2514.67% in 2023 and then skyrocketed by 754.72% in 2024.
  • Over the past 5 years, Novartis Ag's Other Non-Current Liabilities (Quarter) stood at $6.2 billion in 2021, then dropped by 20.51% to $4.9 billion in 2022, then fell by 7.81% to $4.5 billion in 2023, then dropped by 9.9% to $4.1 billion in 2024, then grew by 1.42% to $4.1 billion in 2025.
  • Its last three reported values are $4.1 billion in Q4 2025, $4.1 billion for Q3 2025, and $4.2 billion during Q2 2025.